Apple must pay Masimo an extra $184M for Apple Watch patent infringement
Apple must pay Masimo an additional $184M in interest for patent infringement related to Apple Watch's blood oxygen feature, on top of the $634M already ordered. Judge rejected Apple's argument against interest, citing Supreme Court guidance. Masimo sought 7% interest, but the judge set it to Masimo's borrowing rate, resulting in $184M after compounding.
How this was made
The 30-second read
Why it matters
The court’s decision adds $184 million in interest, raising total liability and potentially affecting Apple’s quarterly earnings and Masimo’s cash flow.
Market read
Legal cost increase for Apple may weigh on its stock; Masimo may see a modest boost from the judgment.
What to watch
Apple's large cash reserves may absorb the cost without material earnings impact.
Background
Apple previously paid $634 million for a patent‑infringement judgment related to its Apple Watch blood‑oxygen sensor. Masimo sought additional interest on the unpaid amount.
Ticker impact
Apple was ordered to pay an additional $184 million in interest on a prior $634 million patent‑infringement judgment.
likely pressure as the market prices in the added interest expense.
The new interest liability increases total payout and may affect margins, prompting a sell response.
Market effects
Highlights ongoing patent risk for consumer‑electronics firms and may prompt tighter IP diligence.
U.S. tech sector may see modest pullback amid heightened legal exposure.
Limited to companies with similar wearable‑tech patents; broader market effect minimal.
Counterpoint
The interest award may be appealed, so the immediate impact could be overstated.
Key entities
- CompanyApple Inc.
U.S. technology company ordered to pay additional interest.
- CompanyMasimo Corp.
Health‑tech firm receiving the interest award.
